D
Dyne Therapeutics, Inc.
DYN · NASDAQ · Healthcare · 4.8B
Closing price
$16.64
+1.65% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.2×
Enterprise value / EBITDAEV/EBITDA
-2.9×
Free cash flow yieldFCF yield
-19.0%
Return on equityROE
-45.9%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
2.0×
Interest coverage
-75.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.